The Oncology Institute, Inc.TOINASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+139.6%
5Y CAGR+14.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+139.6%/yr
vs -45.8%/yr prior
5Y CAGR
+14.0%/yr
Recent acceleration
Acceleration
+185.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.54 | +10999.7% |
| 2024 | 0.06 | -87.3% |
| 2023 | 0.46 | -2.5% |
| 2022 | 0.48 | -85.0% |
| 2021 | 3.18 | -6.6% |
| 2020 | 3.40 | -15.4% |
| 2019 | 4.02 | -27.2% |
| 2018 | 5.52 | - |